All Posts

Day 2 of Bioshares: One Year On...

Aug 7, 2026

•

2 min read

Eli Lilly's $23 Billion Shopping Spree

Aug 6, 2026

•

1 min read

Day 1 of Bioshares: It’s Snow Problem

Aug 5, 2026

•

1 min read

The Money Equation for Biotechs

Aug 4, 2026

•

8 min read

Time is Brain: The EMVision Story (EMV)

Aug 3, 2026

•

9 min read

Control Bionics: A Quarter’s Worth of Progress

Jul 31, 2026

•

5 min read

The Biggest Tree in Healthcare Stands Tall

Jul 30, 2026

•

2 min read

The Human Side to Healthcare Investing

Jul 29, 2026

•

3 min read

Armchair on stage at Bio Connections

Jul 28, 2026

•

12 min read

Deep Cuts from the Surgeon: What happened with EBR?

Jul 27, 2026

•

3 min read

FDA gives the green light to peptides

Jul 24, 2026

•

3 min read

Designer Genes: The PYC Therapeutics Story (PYC)

Jul 23, 2026

•

10 min read

1 2 3...14

All Posts

Day 2 of Bioshares: One Year On...

Eli Lilly's $23 Billion Shopping Spree

Day 1 of Bioshares: It’s Snow Problem

The Money Equation for Biotechs

Time is Brain: The EMVision Story (EMV)

Control Bionics: A Quarter’s Worth of Progress

The Biggest Tree in Healthcare Stands Tall

The Human Side to Healthcare Investing

Armchair on stage at Bio Connections

Deep Cuts from the Surgeon: What happened with EBR?

FDA gives the green light to peptides

Designer Genes: The PYC Therapeutics Story (PYC)

The Armchair Analyst